| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 292 / 361 | 19th | Q4 |
| Cardiology and Cardiovascular Medicine | 333 / 409 | 18th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
CASE
CASE is Scopus-indexed (Q4, CiteScore 0.7). Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2468-6441Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$950 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is CASE indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q4, CiteScore 0.7.
What quartile is CASE in Scopus?
CASE is Q4 in Radiology, Nuclear Medicine and Imaging (rank 292 of 361) and Q4 in Cardiology and Cardiovascular Medicine (rank 333 of 409), by CiteScore 2025.
What is the impact factor of CASE?
CASE is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.7, quartile Q4, 19th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.205, quartile Q4, with an H-index of 10.
How much does it cost to publish in CASE?
The publisher lists an article processing charge of about US$950 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes CASE and what is its ISSN?
CASE is published by Elsevier B.V. Its ISSN is 2468-6441.
Is CASE in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is CASE open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is CASE? — open metrics via OpenAlex
CASE has an h-index of 14 and a 2-year mean of 0.37 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q4. On 2-year citations it ranks #279 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
CASE published 115 papers in 2025; its busiest recent year was 2020 with 130. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in CASE? — latest 94 articles, 2025–2026
In its latest 94 research articles (2025–2026), authors are most often from United States (67.3%), Australia (4.3%) and Iran (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for CASE? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration67.3% of recent authorship from United States
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.